HB1556: Prescription Monitoring Program; adds controlled substances included in Schedule V and naloxone.

This vote on HB1556 was held in the House. The vote was on this subject: “Reported from Health, Welfare and Institutions”. This vote passed 21-0-1.

Yes

Didn’t Vote

Cliff Hayes (D-91)

Explanation

At left is the tally of who voted how on this bill.

It’s important to understand that most bills are voted on multiple times, and the vote is not necessarily simply whether or not the bill should pass. Be sure to look at the bill’s history to determine what, exactly, was being voted on, and at what point in the bill’s progress.

Progress History

01/19/2018 Committee

01/19/2018 Presented and ordered printed 18104962D

01/19/2018 Referred to Committee on Health, Welfare and Institutions

01/22/2018 Assigned HWI sub: Subcommittee #2

01/23/2018 Impact statement from VDH (HB1556)

01/30/2018 Subcommittee recommends reporting (10-Y 0-N)

02/01/2018 Reported from Health, Welfare and Institutions (21-Y 0-N)

02/05/2018 Read first time

02/06/2018 Read second time and engrossed

02/07/2018 Read third time and passed House (95-Y 2-N)

02/07/2018 VOTE: PASSAGE (95-Y 2-N)

02/08/2018 Constitutional reading dispensed

02/08/2018 Referred to Committee on Education and Health

02/15/2018 Reported from Education and Health (15-Y 0-N)

02/16/2018 Constitutional reading dispensed (38-Y 0-N)

02/19/2018 Read third time

02/19/2018 Passed Senate (40-Y 0-N)

02/21/2018 Enrolled

02/21/2018 Bill text as passed House and Senate (HB1556ER)

02/21/2018 Impact statement from VDH (HB1556ER)

02/21/2018 Signed by Speaker

02/23/2018 Signed by President

02/26/2018 Enrolled Bill communicated to Governor on February 26, 2018

02/26/2018 G Governor's Action Deadline Midnight, March 5, 2018

03/05/2018 G Approved by Governor-Chapter 185 (effective 7/1/18)

03/05/2018 G Acts of Assembly Chapter text (CHAP0185)

HB1556: Prescription Monitoring Program; adds controlled substances included in Schedule V and naloxone.

Yes

Didn’t Vote

Your Bill Portfolio